Company · CIK 0001590750 · SIC 2834 — Pharmaceutical Preparations · Nasdaq
Viridian Therapeutics, Inc.\DE · VRDN
Insider activity reported against this company. All insider holders · On EDGAR ↗
Reported at this company — common stock
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 MForm 4 → | Aug 20, 8:05 pm EDT | Jennifer TousignantChief Legal Officer | 10,000 | $14.41 | $144,100 | 10,000 | — | |
| Aug 19, 2026 SForm 4 → | Aug 20, 8:05 pm EDT | Jennifer TousignantChief Legal Officer | 14,212 | $24.50 | $348,194 | 0 | −100% | |
| Aug 14, 2026 MForm 4 → | Aug 18, 5:34 pm EDT | Radhika TripuraneniChief Medical Officer | 40,000 | $13.21 | $528,400 | 40,000 | — |
Reported at this company — derivatives (options, RSUs, warrants)
| Trade | Reported (ET) | Insider | Shares | Avg price | Total | Owned after | Δ stake | Flags |
|---|---|---|---|---|---|---|---|---|
| Aug 19, 2026 MForm 4 → | Aug 20, 8:05 pm EDT | Jennifer TousignantChief Legal Officer | 10,000 | — | — | 114,072 | — | |
| Aug 14, 2026 MForm 4 → | Aug 18, 5:34 pm EDT | Radhika TripuraneniChief Medical Officer | 40,000 | — | — | 0 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Christopher W. CainDirector | 32,341 | — | — | 32,341 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Jeffrey Robert AjerDirector | 32,341 | — | — | 32,341 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Jennifer K. MosesDirector | 32,341 | — | — | 32,341 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Sarah GheuensDirector | 32,341 | — | — | 32,341 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Tomas KiselakDirector | 32,341 | — | — | 32,341 | — | |
| Jul 1, 2026 AForm 4 → | Jul 2, 4:15 pm EDT | Arlene MorrisDirector | 32,341 | — | — | 32,341 | — |